AKT1 and cancer: PI3K–Akt is a classic EMT signaling pathway that mediates EMT in cancer and wound healing [29], and our results also confirm that miR–618 inhibits the PI3K–Akt signaling pathway and leads to keratinocytes’ dysfunction.